HLA-A2.1-restricted T cells react to SEREX-defined tumor antigen CML66L and are suppressed by CD4+CD25+ regulatory T cells.

Source:http://linkedlifedata.com/resource/pubmed/id/17346430

Download in:

View as

General Info

PMID
17346430